What's Happening?
A secondary analysis of the 'I Can!' randomized controlled trial, published in the Journal of the National Cancer Institute, indicates that a 12-month remotely delivered exercise program was associated with slower epigenetic aging in breast cancer survivors.
This was observed when compared to an attention-matched health and wellness program. The study, which included 124 participants, found that specific epigenetic clocks, GrimAge2 and DNAmFitAge, showed significantly slower aging trajectories in the exercise group. For instance, the gap between chronological and epigenetic age decreased by 0.92 years in the exercise group versus 0.19 years in the control group over 12 months. The findings also linked faster epigenetic aging with worsening attention and self-reported cognitive ability. Researchers identified exercise-associated DNA methylation changes involving pathways related to brain-derived neurotrophic factor (BDNF), suggesting a potential biological mechanism for the observed effects.
Why It's Important?
This research is significant for U.S. healthcare and public health initiatives, particularly in cancer survivorship. As the number of breast cancer survivors living for decades post-treatment increases, addressing long-term health consequences like accelerated aging and cognitive impairment becomes crucial. The study suggests that exercise, a modifiable lifestyle factor, could be a valuable intervention to mitigate these issues. If validated, these findings could lead to more targeted exercise recommendations for breast cancer survivors, potentially improving their quality of life and reducing the burden of age-related health problems. The identification of BDNF-related pathways as a potential mechanism offers a deeper understanding of how physical activity impacts biological aging and cognitive health, which could inform future therapeutic strategies. This could also influence insurance coverage and support for exercise programs as part of comprehensive cancer care.
What's Next?
The authors emphasize that these findings are preliminary and hypothesis-generating, necessitating larger confirmatory studies. Future research will need to prospectively validate the proposed pathway: exercise leading to epigenetic remodeling, altered neuroplasticity-related signaling, and ultimately greater cognitive resilience. Larger studies with longer follow-up periods are required to determine if slowing epigenetic aging translates into clinically meaningful reductions in outcomes such as dementia, cardiovascular disease, cancer recurrence, or mortality. Additionally, research should aim to generalize these findings to a broader and more diverse population of breast cancer survivors, as the current study population was predominantly White and well-educated. The potential for exercise to influence specific biological aging processes, rather than producing a universal change across all epigenetic measures, also warrants further investigation.
Beyond the Headlines
Beyond the immediate clinical implications, this study touches upon the broader understanding of aging and the potential for lifestyle interventions to influence biological processes. The concept of 'epigenetic clocks' as biomarkers for biological age, distinct from chronological age, highlights a shift in how aging is measured and understood. The fact that exercise can influence these markers suggests that the biological aging associated with cancer and its treatments may be more modifiable than previously thought. This could lead to a re-evaluation of how 'anti-aging' interventions are perceived, moving away from unvalidated commercial claims towards evidence-based lifestyle modifications. Ethically, this research underscores the importance of accessible and effective post-treatment care for cancer survivors, emphasizing holistic approaches that address both physical and cognitive well-being. It also opens avenues for exploring the interplay between physical activity, epigenetics, and cognitive function in other populations facing accelerated aging or cognitive decline.
